Immunocore (IMCR) News Today $29.58 -0.55 (-1.83%) Closing price 04:00 PM EasternExtended Trading$29.58 +0.01 (+0.02%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Immunocore Holdings plc (NASDAQ:IMCR) Shares Acquired by BIT Capital GmbHBIT Capital GmbH grew its stake in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 182.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 67,840 shares of the companMarch 28 at 6:32 AM | marketbeat.comImmunocore (NASDAQ:IMCR) Shares Gap Up - Time to Buy?Immunocore (NASDAQ:IMCR) Shares Gap Up - Here's What HappenedMarch 27 at 11:37 AM | marketbeat.comInsiders Make Huge Purchases of These 4 Biotech StocksMarch 26 at 8:40 AM | 247wallst.comImmunocore Holdings plc (NASDAQ:IMCR) Given Average Recommendation of "Moderate Buy" by AnalystsMarch 26 at 2:57 AM | americanbankingnews.comImmunocore Holdings plc (IMCR): Among Stocks Receiving the Most Insider Love in MarchMarch 25 at 3:33 PM | msn.comImmunocore Holdings plc (NASDAQ:IMCR) Receives Consensus Rating of "Moderate Buy" from AnalystsImmunocore Holdings plc (NASDAQ:IMCR - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the thirteen analysts that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and eightMarch 22, 2025 | marketbeat.comImmunocore (NASDAQ:IMCR) Shares Gap Up on Insider Buying ActivityMarch 22, 2025 | americanbankingnews.comImmunocore (NASDAQ:IMCR) Shares Gap Up Following Insider Buying ActivityImmunocore (NASDAQ:IMCR) Shares Gap Up on Insider Buying ActivityMarch 21, 2025 | marketbeat.comInsider Buying: Immunocore Holdings plc (NASDAQ:IMCR) Director Acquires 807,338 Shares of StockImmunocore Holdings plc (NASDAQ:IMCR - Get Free Report) Director Bros. Advisors Lp Baker purchased 807,338 shares of the firm's stock in a transaction that occurred on Monday, March 17th. The shares were acquired at an average cost of $29.72 per share, for a total transaction of $23,994,085.36. Following the purchase, the director now owns 2,144,060 shares of the company's stock, valued at $63,721,463.20. This represents a 60.40 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.March 20, 2025 | marketbeat.comImmunocore Holdings plc (NASDAQ:IMCR) Director Bros. Advisors Lp Baker Buys 807,338 SharesMarch 20, 2025 | insidertrades.comImmunocore Holdings plc (NASDAQ:IMCR) Shares Purchased by Primecap Management Co. CAPrimecap Management Co. CA increased its holdings in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 8.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,668,550 shares of the company's sMarch 19, 2025 | marketbeat.comImmunocore at Barclays Conference: Strategic Growth and ChallengesMarch 13, 2025 | investing.comImmunocore (NASDAQ:IMCR) Receives Buy Rating from Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and set a $71.00 price objective on shares of Immunocore in a research report on Wednesday.March 13, 2025 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Immunocore (NASDAQ:IMCR)HC Wainwright reiterated a "buy" rating and set a $100.00 price target on shares of Immunocore in a research report on Wednesday.March 13, 2025 | marketbeat.comImmunocore reports promising HIV trial resultsMarch 12, 2025 | investing.comImmunocore Reports Initial Data from Phase 1/2 Trial of HIV Functional Cure Candidate IMC-M113V at CROI 2025March 12, 2025 | nasdaq.comMizuho Securities Keeps Their Hold Rating on Immunocore Holdings (IMCR)March 12, 2025 | markets.businessinsider.comImmunocore (NASDAQ:IMCR) Hits New 12-Month Low - Time to Sell?Immunocore (NASDAQ:IMCR) Reaches New 52-Week Low - What's Next?March 12, 2025 | marketbeat.comBarclays Remains a Buy on Immunocore Holdings (IMCR)March 11, 2025 | markets.businessinsider.comImmunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025March 10, 2025 | globenewswire.comImmunocore (NASDAQ:IMCR) Receives Equal Weight Rating from Morgan StanleyMorgan Stanley restated an "equal weight" rating and set a $35.00 target price on shares of Immunocore in a report on Friday.March 8, 2025 | marketbeat.comImmunocore assumed with an Equal Weight at Morgan StanleyMarch 7, 2025 | markets.businessinsider.comImmunocore Holdings (IMCR) Receives a Buy from Goldman SachsMarch 3, 2025 | markets.businessinsider.comImmunocore Holdings (IMCR) Gets a Hold from Mizuho SecuritiesMarch 3, 2025 | markets.businessinsider.comImmunocore to present at upcoming investor conferencesMarch 3, 2025 | globenewswire.comImmunocore FY2027 EPS Forecast Increased by HC WainwrightImmunocore Holdings plc (NASDAQ:IMCR - Free Report) - Stock analysts at HC Wainwright upped their FY2027 earnings estimates for shares of Immunocore in a research note issued to investors on Friday, February 28th. HC Wainwright analyst P. Trucchio now expects that the company will post earnings pMarch 3, 2025 | marketbeat.comCantor Fitzgerald Raises Earnings Estimates for ImmunocoreImmunocore Holdings plc (NASDAQ:IMCR - Free Report) - Investment analysts at Cantor Fitzgerald increased their FY2025 EPS estimates for shares of Immunocore in a research report issued on Thursday, February 27th. Cantor Fitzgerald analyst E. Schmidt now anticipates that the company will earn ($1.March 3, 2025 | marketbeat.comThe Immunocore Holdings plc (NASDAQ:IMCR) Full-Year Results Are Out And Analysts Have Published New ForecastsMarch 1, 2025 | uk.finance.yahoo.comImmunocore (NASDAQ:IMCR) Receives "Buy" Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $100.00 target price on shares of Immunocore in a report on Friday.March 1, 2025 | marketbeat.comLeerink Partnrs Predicts Immunocore Q1 EarningsImmunocore Holdings plc (NASDAQ:IMCR - Free Report) - Equities research analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for Immunocore in a research note issued to investors on Wednesday, February 26th. Leerink Partnrs analyst J. Chang forecasts that the company will post earningsMarch 1, 2025 | marketbeat.comNeedham & Company LLC Reaffirms "Buy" Rating for Immunocore (NASDAQ:IMCR)Needham & Company LLC reaffirmed a "buy" rating and set a $71.00 target price on shares of Immunocore in a research note on Thursday.February 28, 2025 | marketbeat.comImmunocore price target lowered to $85 from $88 at OppenheimerFebruary 27, 2025 | markets.businessinsider.comImmunocore: A Commercial Biotech Nearing Its Pivotal Break-Even PointFebruary 27, 2025 | seekingalpha.comImmunocore (NASDAQ:IMCR) Releases Quarterly Earnings ResultsImmunocore (NASDAQ:IMCR - Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.47) EPS for the quarter, missing the consensus estimate of ($0.31) by ($0.16). Immunocore had a negative return on equity of 12.84% and a negative net margin of 15.87%.February 27, 2025 | marketbeat.comLeerink Partnrs Weighs in on Immunocore Q2 EarningsImmunocore Holdings plc (NASDAQ:IMCR - Free Report) - Stock analysts at Leerink Partnrs issued their Q2 2025 earnings per share (EPS) estimates for shares of Immunocore in a research note issued on Wednesday, February 26th. Leerink Partnrs analyst J. Chang expects that the company will post earniFebruary 27, 2025 | marketbeat.comImmunocore Holdings PLC (IMCR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...February 27, 2025 | finance.yahoo.comPrincipal Financial Group Inc. Has $14.84 Million Stock Position in Immunocore Holdings plc (NASDAQ:IMCR)Principal Financial Group Inc. reduced its holdings in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 8.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 502,857 shares of the company's stock after selling 43,461 shares during the quarterFebruary 27, 2025 | marketbeat.comImmunocore Holdings plc (IMCR) Q4 2024 Earnings Call TranscriptFebruary 26, 2025 | seekingalpha.comImmunocore (NASDAQ:IMCR) Shares Gap Down After Earnings MissImmunocore (NASDAQ:IMCR) Shares Gap Down After Earnings MissFebruary 26, 2025 | marketbeat.comImmunocore reports Q4 EPS (47c), consensus (16c)February 26, 2025 | markets.businessinsider.comImmunocore reports fourth quarter and full year 2024 financial results and provides a business updateFebruary 26, 2025 | globenewswire.comImmunocore Holdings plc (NASDAQ:IMCR) Receives Average Rating of "Moderate Buy" from BrokeragesImmunocore Holdings plc (NASDAQ:IMCR - Get Free Report) has received an average rating of "Moderate Buy" from the thirteen brokerages that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommenFebruary 24, 2025 | marketbeat.comImmunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025February 19, 2025 | globenewswire.comImmunocore (IMCR) Projected to Post Quarterly Earnings on WednesdayImmunocore (NASDAQ:IMCR) will be releasing earnings before the market opens on Wednesday, February 26.February 19, 2025 | marketbeat.comImmunocore Holdings plc (NASDAQ:IMCR) Short Interest UpdateImmunocore Holdings plc (NASDAQ:IMCR - Get Free Report) saw a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 7,340,000 shares, a growth of 9.4% from the January 15th total of 6,710,000 shares. Based on an average trading volume of 264,000 shares, the days-to-cover ratio is currently 27.8 days. Currently, 15.1% of the company's shares are sold short.February 17, 2025 | marketbeat.comMorgan Stanley Remains a Hold on Immunocore Holdings (IMCR)February 6, 2025 | markets.businessinsider.comImmunocore Holdings plc (NASDAQ:IMCR) Receives Average Recommendation of "Moderate Buy" from BrokeragesImmunocore Holdings plc (NASDAQ:IMCR - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the thirteen ratings firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, four have given a hold rating aJanuary 30, 2025 | marketbeat.comHC Wainwright Estimates Immunocore FY2029 EarningsImmunocore Holdings plc (NASDAQ:IMCR - Free Report) - Equities researchers at HC Wainwright issued their FY2029 earnings per share (EPS) estimates for shares of Immunocore in a note issued to investors on Monday, January 27th. HC Wainwright analyst P. Trucchio forecasts that the company will postJanuary 28, 2025 | marketbeat.comImmunocore Holdings: Buy Rating Backed by Promising Pipeline and Strategic AdvancementsJanuary 27, 2025 | markets.businessinsider.comCrossmark Global Holdings Inc. Increases Stock Position in Immunocore Holdings plc (NASDAQ:IMCR)Crossmark Global Holdings Inc. increased its stake in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 36.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 38,020 shares of the company's stock after purchasinJanuary 25, 2025 | marketbeat.com Remove Ads Get Immunocore News Delivered to You Automatically Sign up to receive the latest news and ratings for IMCR and its competitors with MarketBeat's FREE daily newsletter. Email Address IMCR Media Mentions By Week IMCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMCR News Sentiment▼0.980.78▲Average Medical News Sentiment IMCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMCR Articles This Week▼85▲IMCR Articles Average Week Remove Ads Get Immunocore News Delivered to You Automatically Sign up to receive the latest news and ratings for IMCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies KRYS News Today NUVL News Today CYTK News Today VRNA News Today GRFS News Today ELAN News Today ADMA News Today PTCT News Today RNA News Today ACLX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMCR) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunocore Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunocore With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
